Clinical study on biapenem in the field of internal medicine

Abstract

A new antibiotic, biapenem (BIPM), was administered for 4.5-14 days at daily doses of 600mg to 8 patients, including 4 cases of pneumonia, 2 cases of acute exacerbation of chronic bronchitis, lease of bronchial asthma with infection and 1 case of mycoplasmal pneumonia.
The clinical effects were good in 5 cases, poor in 2 cases and not evaluable in 1 case. Side effects were not observed in any of these patients.